Samuel Zachary Goldhaber, M.D.
This page shows the publications co-authored by Samuel Goldhaber and Joseph Loscalzo.
Urokinase versus tissue plasminogen activator in pulmonary embolism. Lancet. 1988 Oct 15; 2(8616):915.
Utility of cross-linked fibrin degradation products in the diagnosis of pulmonary embolism. Am Heart J. 1988 Aug; 116(2 Pt 1):505-8.
Thrombolytic therapy of acute pulmonary embolism: current status and future potential. J Am Coll Cardiol. 1987 Nov; 10(5 Suppl B):96B-104B.
Tissue plasminogen activator and acute pulmonary embolism. J Cell Biochem. 1988 Dec; 38(4):303-12.
Randomised controlled trial of recombinant tissue plasminogen activator versus urokinase in the treatment of acute pulmonary embolism. Lancet. 1988 Aug 06; 2(8606):293-8.
Recombinant tissue plasminogen activator in patients with pulmonary embolism: correlation of fibrinolytic specificity and efficacy. Circulation. 1987 Jun; 75(6):1200-3.
Perspectives on treatment of acute pulmonary embolism with tissue plasminogen activator. Semin Thromb Hemost. 1987 Apr; 13(2):171-7.
Acute pulmonary embolism treated with tissue plasminogen activator. Lancet. 1986 Oct 18; 2(8512):886-9.
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.